Callan Family Office LLC purchased a new stake in IDEX Corporation (NYSE:IEX - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 12,020 shares of the industrial products company's stock, valued at approximately $2,728,000.
Several other institutional investors also recently bought and sold shares of IEX. Optiver Holding B.V. acquired a new position in shares of IDEX during the 1st quarter worth approximately $27,000. SJS Investment Consulting Inc. grew its position in shares of IDEX by 104.1% in the first quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company's stock valued at $28,000 after purchasing an additional 76 shares in the last quarter. Laurel Wealth Advisors LLC acquired a new stake in shares of IDEX in the fourth quarter valued at approximately $27,000. CYBER HORNET ETFs LLC acquired a new stake in shares of IDEX in the second quarter valued at approximately $35,000. Finally, Root Financial Partners LLC lifted its position in IDEX by 57.6% during the first quarter. Root Financial Partners LLC now owns 208 shares of the industrial products company's stock worth $39,000 after buying an additional 76 shares in the last quarter. 97.96% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research analysts recently weighed in on IEX shares. Stifel Nicolaus increased their price objective on IDEX from $257.00 to $268.00 and gave the stock a "buy" rating in a research report on Thursday, July 30th. Citigroup lifted their target price on IDEX from $252.00 to $269.00 and gave the company a "buy" rating in a research report on Thursday, July 30th. DA Davidson upped their price target on IDEX from $230.00 to $240.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Royal Bank Of Canada increased their price target on IDEX from $261.00 to $280.00 and gave the stock an "outperform" rating in a report on Thursday, July 30th. Finally, Robert W. Baird set a $257.00 price objective on IDEX in a research report on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $260.80.
View Our Latest Analysis on IDEX
Insider Buying and Selling at IDEX
In other news, CAO Lisa M. Anderson sold 385 shares of the stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total transaction of $91,857.15. Following the completion of the sale, the chief accounting officer owned 4,327 shares in the company, valued at approximately $1,032,378.93. This represents a 8.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.50% of the company's stock.
Trending Headlines about IDEX
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Analysts raised several forward earnings forecasts. Zacks Research lifted its FY2026 EPS estimate to $8.70 from $8.46, Q3 2026 to $2.20 from $2.17, Q1 2027 to $2.11 from $2.09, FY2027 to $9.21 from $9.20, and FY2028 to $10.45 from $10.27. The upgrades suggest expectations for improving earnings momentum beyond the current year. IDEX analyst estimates
- Positive Sentiment: Longer-term earnings growth remains a key support. The FY2028 forecast implies continued expansion from the approximately $8.70 expected for FY2026, while the company’s latest reported quarter exceeded consensus estimates for both revenue and EPS. IDEX financial information
- Neutral Sentiment: Board changes may increase investor focus on governance and valuation. IDEX announced a board resignation and a governance adjustment. The development does not provide a clear operating-impact signal, but investors may scrutinize leadership, capital allocation, and whether the company’s premium valuation is justified. IDEX board resignation and governance adjustment
- Negative Sentiment: Some estimates were reduced. Zacks cut its Q2 2027 EPS forecast to $2.33 from $2.43 and its Q2 2028 forecast to $2.43 from $2.54. These isolated reductions temper the broader upgrade story and could limit upside if investors view them as signs of uneven demand or execution. IDEX revised earnings estimates
IDEX Price Performance
Shares of NYSE IEX opened at $234.57 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15. The company has a market cap of $17.29 billion, a price-to-earnings ratio of 33.75, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. The stock's 50-day moving average is $227.88 and its two-hundred day moving average is $212.87. IDEX Corporation has a 1-year low of $158.19 and a 1-year high of $243.80.
IDEX (NYSE:IEX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating analysts' consensus estimates of $2.11 by $0.21. IDEX had a net margin of 14.49% and a return on equity of 15.69%. The company had revenue of $920.60 million for the quarter, compared to the consensus estimate of $905.38 million. During the same period in the prior year, the firm posted $2.07 EPS. The company's quarterly revenue was up 6.4% compared to the same quarter last year. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Analysts forecast that IDEX Corporation will post 8.82 EPS for the current fiscal year.
IDEX Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were issued a $0.73 dividend. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Monday, July 6th. IDEX's dividend payout ratio is presently 42.01%.
About IDEX
(
Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company's core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.